Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact

Published:2020-12-09 Issue:2 Volume:35 Page:417-421
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Golbari N.M.¹,Walt J.M.²,Blauvelt A.³^ORCID,Ryan C.⁴,Kerkhof P.⁵,Kimball A.B.⁶^ORCID

Affiliation:

1. Downstate Medical Center Brooklyn NY USA

2. PRI Healthcare Solutions Paramus NJ USA

3. Oregon Medical Research Center Portland OR USA

4. Charles Institute of Dermatology University College Dublin Dublin Ireland

5. International Psoriasis Council St. Louis MO USA

6. Harvard Medical School and Beth Israel Deaconess Medical Center Boston MA USA

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16966

Reference20 articles.

1. Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council

2. How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review

3. Defining and treating moderate plaque psoriasis: a dermatologist survey

4. Guidelines of care for the management of psoriasis and psoriatic arthritis

5. Current severe psoriasis and the Rule of Tens

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serious adverse events associated with systemic treatments for psoriasis: a network meta-analysis of observational studies and randomized controlled trials;Cochrane Database of Systematic Reviews;2024-04-18

2. Psoriasis and Related Disorders;Rook's Textbook of Dermatology;2024-03-19

3. Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands;Advances in Therapy;2024-02-24

4. Factors Influencing Major Life-Changing Decisions in Patients with Psoriasis: A Cross-sectional Study;Acta Dermato-Venereologica;2023-10-10

5. Disease modification in inflammatory skin disorders: opportunities and challenges;Nature Reviews Drug Discovery;2023-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3